CLINICAL_TRIALS
trial_result
· 2012-02-22
Clinical Trial Update: Study of Eszopiclone Compared to Placebo in the Treatment of Insomnia Secondary to Perimenopause/Menopause [Phase 3]
Summary
A Phase 3 trial evaluating eszopiclone versus placebo for insomnia associated with perimenopause/menopause has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sumitomo Pharma America, Inc. | Conditions: Insomnia | Phase 3 | Status: COMPLETED